Align Technology, Inc. (NASDAQ: ALGN ) is given an average rating of “Moderate Buy” by brokerages

Align Technology, Inc. (NASDAQ:ALGN – Get Rating ) has received an average recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $535.25.

A number of analysts recently commented on the company. Morgan Stanley decreased their price objective on Align Technology from $524.00 to $479.00 and set an “overweight” rating for the company in a report on Wednesday, June 15th. Piper Sandler reduced their target price on Align Technology from $600.00 to $440.00 in a report on Thursday, April 28th. Robert W. Baird decreased their target price on Align Technology from $625.00 to $510.00 and set an “outperform” rating for the company in a report on Thursday, April 28th. TheStreet lowered Align Technology from a “b-” rating to a “c+” rating in a report on Monday, April 25th. Finally, UBS Group decreased their target price on Align Technology from $620.00 to $500.00 and set a “buy” rating for the company in a report on Tuesday, April 26th.

Shares of ALGN stock opened at $261.52 on Friday. The company has a market cap of $20.61 billion, a PE ratio of 29.42, a price-to-earnings-growth ratio of 3.99 and a beta of 1.77. The stock has a fifty day moving average of $263.45 and a two hundred day moving average of $405.44. Align Technology has a fifty-two week low of $225.86 and a fifty-two week high of $737.45.

(Ad)

What is the highest yielding stock you have ever owned? Dividends on these stocks have risen so quickly over the years that they now give us an average of 26%!

When you start getting 26% of your money, your financial problems tend to almost evaporate.

Align Technology (NASDAQ:ALGN – Get Rating ) last posted its quarterly earnings data on Wednesday, April 27th. The medical equipment provider reported $1.70 EPS for the quarter, missing analysts’ consensus estimates of $1.99 by ($0.29). The firm had revenue of $973.22 million for the quarter, compared to analysts’ estimates of $1 billion. Align Technology had a return on equity of 19.90% and a net margin of 17.51%. In the same quarter last year, the company earned $2.51 earnings per share. As a group, research analysts anticipate that Align Technology will post 9 earnings per share for the current year.

In other Align Technology news, Director C Raymond Larkin, Jr. bought 1,000 shares of Align Technology stock in a transaction that occurred on Friday, May 13th. The stock was bought at an average price of $264.42 per share, for a total transaction of $264,420.00. Following the completion of the acquisition, the director now owns 18,190 shares of the company’s stock, valued at approximately $4,809,799.80. The acquisition was disclosed in a filing with the Securities and Exchange Commission, which is available at this link. Also, CEO Joseph M. Hogan acquired 6,700 shares of the firm’s stock in a transaction that occurred on Wednesday, May 4th. The shares were purchased at an average price of $298.48 per share, for a total value of $1,999,816.00. Following the purchase, the chief executive officer now directly owns 174,801 shares in the company, valued at approximately $52,174,602.48. Disclosure of this purchase can be found here. 0.64% of shares are owned by corporate insiders.

Several institutional investors have recently added to or reduced their stakes in ALGN. JW Cole Advisors Inc. bought a new position in Align Technology during the first quarter valued at $29,000. Tsfg LLC increased its position in Align Technology by 200.0% during the first quarter. Tsfg LLC now owns 75 shares of the medical equipment provider’s stock valued at $33,000 after buying an additional 50 shares during the last quarter. Mizuho Securities Co. Ltd. acquired a new stake in Align Technology during the 4th quarter valued at $39,000. Massmutual Trust Co. FSB ADV boosted its position in Align Technology by 60.0% in the second quarter. Massmutual Trust Co. FSB ADV now owns 176 shares of the medical equipment provider’s stock valued at $42,000 after buying an additional 66 shares during the last quarter. Finally, Gradient Investments LLC boosted its position in Align Technology by 1,428.6% in the first quarter. Gradient Investments LLC now owns 107 shares of the medical equipment provider’s stock valued at $47,000 after buying an additional 100 shares during the last quarter. Institutional investors and hedge funds own 88.17% of the company’s shares.

Align Technology Company Profile (Get Rating)

Align Technology, Inc, a medical device company, designs, manufactures and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general dentists, as well as restorative and cosmetic dentistry. It operates in two segments, Clear Aligner; and scanners and services.

More information

Analyst Recommendations for Align Technology (NASDAQ:ALGN)

This instant news alert is generated by narrative science technology and financial data from MarketBeat to provide readers with the fastest and most accurate reporting. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1000 in Align Technology right now?

Before you consider Align Technology, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients daily. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market takes a nosedive … and Align Technology wasn’t on the list.

Although Align Technology currently has a “Buy” rating among analysts, the top-rated analysts think these five stocks are better buys.

See the 5 stocks here

Leave a Comment

Your email address will not be published.